comparemela.com

Latest Breaking News On - European renal association congress - Page 15 : comparemela.com

New Dialysis Technique Boosts Survival in Kidney Failure

High-dose hemodiafiltration led to substantially better survival of patients with end-stage kidney disease compared with conventional hemodialysis after a median 30 months in a large, prospective study.

Netherlands
United-kingdom
London
City-of
Germany
Berlin
Peterj-blankestijn
Andrew-davenport
Matthias-rose
University-medical-center
University-college-london
European-renal-association-congress

Renal Biopsy Data Supports Long-Term Voclosporin Use for Lupus Nephritis

Data from an analysis of kidney biopsies from the AURORA 2 trial presented at CCR East 2023 offer new insight into the long-term histological impact of voclosporin use on renal function in patients with lupus nephritis.

Samir-parikh
Aurinia-pharmaceuticals-inc
European-renal-association-congress
European-renal-association
Clinical-congress
Drug-administration
Ohio-state-university-wexner-medical-center
Ohio-state-university-wexler-medical-center
Clinical-rheumatology
Kidney-biopsies
Trial-evaluating-voclosporin
Aurinia-pharmaceutical

Poxel SA: Poxel Announces PXL770 Granted Orphan Drug Designation from the U.S. FDA for Autosomal-Dominant Polycystic Kidney Disease (ADPKD)

Completion of preclinical studies support potential to advance PXL770 into Phase 2 development for ADPKD Compelling preclinical efficacy data confirm strategic focus for PXL770 in rare metabolic

Paris
France-general
France
China
Boston
Massachusetts
United-states
Japan
Tokyo
Arthur-rouill
Thomas-kuhn
Sumitomo-pharma

Prague awards congress ambassadors

Prague awards congress ambassadors
c-mw.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from c-mw.net Daily Mail and Mail on Sunday newspapers.

Italy
Czech-republic
Japan
Prague
Praha
Hlavníesto
Alexandria
Al-iskandariyah
Egypt
France
Motol
Stredoceský

Unicycive Announces Second Quarter Financial Results and Provides Business Update

16.08.2022 - On track to file New Drug Application for Renazorb, the first proprietary nanoparticle-based phosphate binder for Chronic Kidney Disease (CKD) patients, by end of 2023 Signed first global partnership for rights to Renazorb in China with Lee’s .

China
Paris
France-general
France
Hong-kong
Shalabh-gupta
European-renal-association-congress
Lee-pharmaceutical-hk-limited
Drug-administration
Company-renazorb
Nasdaq
Takeda-pharmaceutical-company

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.